![]() | ![]() |
Formats:
|
||||||||||||||
A recyclable fluorous organocatalyst for Diels-Alder reactions a Fluorous Technologies, Inc., University of Pittsburgh Applied Research Center, 970 William Pitt Way, Pittsburgh, Pennsylvania 15238 b Department of Chemistry, University of Pittsburgh, Pittsburgh, Pennsylvania 15260 * Corresponding author. Tel.: +412-826-3062; fax: +1-412-826-3053; e-mail: w.zhang/at/fluorous.com. See other articles in PMC that cite the published article.Abstract Chiral fluorous imidazolidinone catalyst 2 provides consistently high enantioselectivities in Diels-Alder reactions of dienes and α, β-unsaturated aldehydes. The catalyst can be readily separated from the reaction products by fluorous solid-phase extraction, and recovered in excellent purity for direct reuse. Over the past decade, much interest has been devoted to the development of highly efficient organocatalysts for a variety of reactions, and the pace of growth in this field of chemistry has been breathtaking.1–3 However, the need for high loading and separation of the organocatalyst from the product are still the issues need to be addressed in this area.4,5 Fluorous organocatalysts are of high interest because they are soluble in common reaction solvents, yet they can be easily separated from the reaction mixture for subsequent reuse.6,7 Recently, enantioselective Michael additions have been achieved with fluorous pyrrolidine derivatives as recyclable catalysts.8 Chiral imidazolidinone 1 (Scheme 1
The only structural difference between the fluorous catalyst 2 and the original imidazolidinone 1 is that the fluorous tag13 (p-C8F17CH2CH2-C6H4-) is attached to the N-methyl group. Since the single fluorous tag is away from the functional group for catalytysis,9 it was hypothesized that this design would not affect the activity of the catalyst. A simple three-step synthesis for the fluorous chiral imidazolidinone 2 is shown in Scheme 2.14 N-Fmoc-amide 3 was obtained by an amide coupling reaction of Fmoc-Phe-OH with a fluorous amine. Subsequent de-protection with piperidine gave aminoamide 4. Treatment of 4 with excess amount of acetone in DMF with microwave irradiation gave the fluorous organocatalyst 2. The overall yield of the three-step synthesis was 66%. Fluorous compound 2 is a stable white solid, and it was kept on bench for weeks without sign of decomposition. A typical Diels-Alder reaction of acrolein and cyclohexadiene was conducted using either standard imidazolidinone 1 or its fluorous variant 2 as the catalyst (Table 1). We first carried out the Diels-Alder reaction with the normal imidazolidinone catalyst by following the literature procedures.9 Acrolein (100 μL, 1.5 mmole) and cyclohexadiene (48 μL, 0.5 mmole) were added into a solution of 1·HCl salt (14 mg, 0.05 mmole) with 2 mL CH3CN-H2O (95:5, v:v). The mixture was stirred for 40 h at 25 °C. An acid-base extraction was utilized to separate the product and recover the organocatalyst.15 Thus, a 0.05M HCl aqueous solution was added to the reaction mixture. The solution was extracted with diethyl ether three times. The organic phases were combined, washed with aqueous NaHCO3, dried and concentrated to give the product 5. The acidic phase was neutralized and extracted with diethyl ether to provide 7.8 mg (65%) of recovered 1. Although the product yield (82%) and ee (88.4%) were comparable to the reported data,9 the recovery of the organocatalyst 1 under the procedures described above was moderate and its purity was only 74% (Table 1, Entry 1). This purity is not sufficient for direct reuse of the recovered catalyst. Moreover, for some reactants (e.g. substance with -OH), the acid-base extraction approach might disturb the functional group in the final product.
![]() The fluorous imidazolidinone 2 catalyzed reactions were then performed with wet solvents and under aerobic atmosphere, same to the reaction conditions described above without much effort of modification.16 After the reaction mixture was stirred for 40 h at room temperature, 0.1 g of MP-carbonate was added and the mixture was shaken for 30 min to free the amine 2. After filtration, the solution was concentrated and then loaded onto a 0.5 g endcapped FluoroFlash® silica gel cartridge for F-SPE.14 The cartridge was first eluted with CH3CN-H2O (65:35) for product 5, then with THF containing 1% Et3N for fluorous catalyst 2. Concentration of the THF fraction gave the fluorous catalyst 2 in good recovery (84%) and excellent purity (99%). The purity was assessed by GC and 1H NMR analyses (Figure 1
To probe the scope of both diene and dienophile (α, β-unsaturated aldehydes) as the reaction components for the fluorous reactions and separations, four other Diels-Alder reactions were conducted (Table 2).16 We found that variation on olefin substituents did not decrease in yield, endo:exo ratios and enantioselectivity (Table 2, Entry 1, Me; Entry 4, Pr) comparing to the control experiments using standard imidazolidinone 1 (Table 2, Entry 2, M,; Entry 5, Pr). Meanwhile, similar stereoselectivity and yield were achieved using the recovered fluorous organocatalyst 2 (Table 2, Entry 1, and Entry 3 with recovered 2). The result confirms the quality of recovered fluorous imidazolidinone catalyst. Furthermore, the [4+2] cycloaddition between acrolein and two acyclic dienes also gave high yields and enantioselectivities (Table 2, Entries 6 and 7). Thus, the generality of the fluorous imidazolidinone 2 as an efficient recyclable organo-catalyst for Diels-Alder reactions has been clearly demonstrated
In addition, a Diels-Alder reaction between acrolein and cyclohexadiene with fluorous organocatalyst 2 was also carried out at gram scale (Table 2, Entry 8).16 The consistent results between the small scale reactions shown in Table 1 and the gram scale reaction is a good indicator that fluorous catalyst has good potential for scale up reactions. In summary, a simple procedure for preparation of a chiral fluorous imidazolidinone catalyst 2 was developed. While the fluorous organocatalyst 2 provides consistently high enantioselectivities in Diels-Alder reactions of dienes and α,β-unsaturated aldehydes, the fluorous catalyst can readily be recovered from the reaction mixture by F-SPE with excellent purity. The recovered fluorous organocatalyst is ready for reuse. Acknowledgments This work was supported by the National Institute of General Medical Sciences SBIR Grants (2R44GM062717-02 and 2R44GM067326-02). Footnotes Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. References 1. Berkessel A, Gröger H. Asymmetric Organocatalysis —— From Biomimetic Concepts to Applications in Asymmetric Synthesis. Wiley-VCH: Weinheim; 2005. 2. Selected reviews on organocatalysis: (a) Dalko P, Moisoan L Angew Chem, Int Ed Engl. 2004;43:5138. [PubMed] (b) Houk KN, List B Acc Chem Res. 2004;37:487. (c) Lelais G, MacMillan DWC Aldrichimica Acta. 2006;39:79. (d) Kočovský P, Malkov A Tetrahedron. 2006;62:255. 3. 4. Baker RT, Kobayshi S, Leitner W. Adv Synth Catal. 2006;348:1337. 5. Rousseau RW. Handbook of Separation Process Technology. Wiley: New York; 1987. 6. General reviews on fluorous chemistry: (a) Gladysz JA, Curran DP, Horváth IT, editors. Handbook of Fluorous Chemistry. Wiley-VCH; Weinheim: 2004. (b) Gladysz JA, Curran DP Tetrahedron. 2002;58:3823. (c) Curran DP Angew Chem, Int Ed Engl. 1998;7:1175. (d) Zhang W Tetrahedron. 2003;59:4475. (e) Zhang W, Curran DP Tetrahedron. 2006 in press 7. Selected papers on fluorous synthesis:(a) Horváth IT, Rábai J Science. 1994;266:72–76. (b) Luo ZY, Zhang QS, Oderaotoshi Y, Curran DP Science. 2001;291:1766. [PubMed] (c) Villard AL, Warrington BH, Ladlow M J Comb Chem. 2004;6:611. [PubMed] (d) Hein JE, Geary LM, Jaworski AA, Hultin PG J Org Chem. 2005;70:9940–9946. [PubMed] (e) Kaleta Z, Makowski BT, Soos T, Dembinski R Org Lett. 2006;8:1625–1628. [PubMed] (f) Zhang W, Lu Y, Chen CHT, Curran DP, Geib S Eur J Org Chem. 2006:2055. 8. (a) Zu L, Li H, Wang J, Yu X, Wang W. Tetrahedron Lett. 2006;47:5131. [PubMed] (b) Zu L, Wang J, Li Hao, Wang W. Org Lett. 2006;8:3077. [PubMed] 9. (a) Ahrendt KA, Borths CJ, MacMillan DWC. J Am Chem Soc. 2000;122:4243. [PubMed] (b) Wilson RM, Jen WS, MacMillan DWC. J Am Chem Soc. 2005;127:11616. [PubMed] 10. (a) Brown SP, Goodwin NC, MacMillan DWC. J Am Chem Soc. 2003;125:1192. [PubMed] (b) Jen WS, Wiener MJJ, MacMillan DWC. J Am Chem Soc. 2000;122:9874. [PubMed] (c) Paras NA, MacMillan DWC. J Am Chem Soc. 2001;123:4370. [PubMed] 11. Benaglia M, Celentano G, Cinquini M, Puglisi A, Cozzi F. Adv Synth Catal. 2002;344:149. 12. Selkälä SA, Tois J, Pihko PM, Koskinen AMP. Adv Synth Catal. 2002;344:941. 13. www.fluorous.com Prof. Dennis P. Curran owns an equity interest in Fluorous Technologies, Inc. 14. General proceduce for the synthesis of fluorous chiral imidazolidinone 2: (1) Amide coupling: A mixture of F-benzylamine (2.9 g, 5 mmole), Fmoc-amino acid (2.1 g, 5.5 mmole), HOBT (0.7 g, 5.5 mmole), DIC (0.65 g, 5.5 mmole) in 15 mL of CH2Cl2 was stirred at 25 °C for 1 h. The reaction mixture was concentrated, mixed with H2O, and extracted with AcOEt. The organic layer was washed with aqueous NaHCO3 and concentrated to give 4.5 g (98% yield) of 3. This product was analyzed by LCMS: m/z = 923 [M+H]+. (2) Fmoc deprotection: Compound 3 (2.3 g, 2.5 mmol) in 20 mL of 1:4 piperidine/DMF was stirred at 25 °C for 1 h. The concentrated reaction mixture was mixed with 50 mL of H2O, extracted with ether. Concentrated organic residue was triturated with hexanes to give desired product 4 as a white solid (1.4 g, 80%). This product was analyzed by GC; LCMS: m/z = 701 [M+H]+; 1H NMR (270 MHz, CDCl3): δ = 7.63 (m, 1H), 7.25 (m, 8H), 4.45 (d, 2H), 3.67 (dd, 1H), 3.32 (dd, 1H), 2.91 (m, 2H), 2.75 (m, 1H), 2.32 (m, 2H) and 1.50 (br, 3H); 13C NMR: (270 MHz, CDCl3): δ = 26.13, 32.99, 41.58, 42,81, 56.51, 102–125 (m, CF2, CF3) 126.91, 128.27, 128.65, 128.80, 129.41, 136.98, 137.91, 138.35, 174.20. (3) Cycloaddition: Compound 4 (0.5 g, 0.7 mmol) and 1.0 mL of acetone in 1.5 mL of DMF was irradiated under a single-mode microwave reactor at 250 w, 150 °C for 30 min. The reaction mixture was concentrated under vacuum. The residue was purified by flash column chromatography with hex:EtOAc (1:1) and then 100% EtOAc to give 0.44 g (85% yield) of 2 as a white solid. The product 2 was analyzed by GC; LCMS and HRMS: m/z = 741.1710 [M+H]+ (100%, calc. mass 741.1774), 594.1 [C8F17CH2CH2C6H5CH2N=C(CH3)2]+ (24%); 1H NMR (270 MHz, CDCl3): δ = 7.30 (m, 5H), 7.12 (m, 4H), 4.65 (d, 1H), 4.08 (d, 1H), 3.89 (t, 1H), 3.17 (m, 2H), 2.88 (m, 2H), 2.34 (m, 2H) 1.71 (br, 1H) 1.22 (s, 3H) and 1.00 (s, 3H); 13C NMR (270 MHz, CDCl3): δ = 26.09, 27.91, 32.85, 36.48, 43,24, 58.82, 104–125 (m, CF2, CF3) 126.91, 127.80, 128.29, 128.59, 129.90, 136.46, 136.64, 138.05, 174.16. 15. General proceduce for the control experiments and the acid-base extraction: To a solution of 1·HCl salt (14 mg, 0.05 mmole) with 2 mL CH3CN-H2O (95:5, v:v), acrolein (100 μL, 1.5 mmole) and cyclohexadiene (48 μL, 0.5 mmole) were added. The solution was stirred for 40 h at 25 °C. Then, 5 mL 0.05M HCl aqueous solution was added to the reaction mixture. The solution was extracted with 4 mL diethyl ether three times. The organic phases were combined, washed with aqueous NaHCO3, dried over Na2SO4 and concentrated to give the product. The acidic phase was neutralized with aqueous NaHCO3 and extracted with 4 mL diethyl ether three times. The combined ethyl ester layer was dried over Na2SO4. Free catalyst 1 (7.8 mg, 65%) was obtained from concentration of the ester layer with a purity of 74%. 16. General proceduce for imidazolidinone-catalyzed Diels-Alder reaction: To a solution of 2 (37 mg, 0.05 mmole) and HCl (0.05 mmole) in 2 mL CH3CN-H2O (95:5, v:v), acrolein (100 μL, 1.5 mmole), and cyclohexadiene (48 μL, 0.5 mmole) was added. The solution was stirred for 40 h at 25 °C. Then, 0.1 g of MP-carbonate was added and the mixture was shaked for 0.5 h to free the amine 2. After filtration, the solution was concentrated and then loaded onto a 0.5 g FluoroFlash® silica gel cartridge for F-SPE. It was first eluted with 4 mL CH3CN-H2O (65:35, v:v) to get the product 5. After that, 4 mL THF with 1% Et3N was used to elute the fluorous catalyst 2 out of the cartridge. Concentrated the THF fraction gave the fluorous catalyst 2 (31 mg) as a white solid in good recovery (84%), and excellent purity (99%). In case of the reactions with cyclopentdiene, 1.5 mmole diene and 0.5 mmole acrolein derivative was used. For the gram scale reaction, 555 mg (0.75 mmole) 1, 1.5 mL acrolein (22 mmole), and 0.75 mL cyclohexadiene (7.5 mmole) were used, and the F-SPE was employed with a 10 g endcapped FluoroFlash® silica gel cartridge. |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||
Org Lett. 2006 Jul 6; 8(14):3077-9.
[Org Lett. 2006]J Am Chem Soc. 2005 Aug 24; 127(33):11616-7.
[J Am Chem Soc. 2005]J Am Chem Soc. 2003 Feb 5; 125(5):1192-4.
[J Am Chem Soc. 2003]J Am Chem Soc. 2005 Aug 24; 127(33):11616-7.
[J Am Chem Soc. 2005]J Am Chem Soc. 2005 Aug 24; 127(33):11616-7.
[J Am Chem Soc. 2005]